COHR

Business Context and Reporting Period

Company: II-VI Incorporated (Note: Metadata listed "COHERENT CORP." but filing text confirms registrant is II-VI Incorporated).

Filing Type: Form 10-Q (Quarterly Report).

Reporting Period: Three months ended September 30, 2007 (First quarter of fiscal 2008).

Business Overview: The company develops, manufactures, and markets high-technology materials and derivative products for precision use in industrial, medical, military, security, and aerospace applications. Operations are organized into four segments: Infrared Optics, Near-Infrared Optics, Military & Materials, and Compound Semiconductor Group.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 20% year-over-year, driven by strong performance in the Near-Infrared Optics and Military & Materials segments.
• Profitability: Net earnings rose 28% to $9.62 million. This was supported by improved operational yields, lower scrap expenses, and foreign currency gains.
• Segment Performance:
  • Near-Infrared Optics: Revenues up 35% and segment earnings up 142%, primarily due to a $13.5 million booking and increased shipments of UV Filter assemblies.
  • Military & Materials: Revenues up 94% and earnings up 530%. This includes the full quarter impact of the Pacific Rare Specialty Metals & Chemicals (PRM) acquisition (completed June 2007) and increased sapphire shipments.
  • Infrared Optics: Revenues increased 5%, but segment earnings declined 16% due to yield issues, capacity constraints in material growth, and higher raw material costs.
  • Compound Semiconductor Group: Revenues increased 8%, turning a loss into a profit ($381k earnings vs. $147k loss), aided by cost reductions from the Vietnam facility. However, bookings dropped 38% due to delays in medical imaging orders.
• Accounting Change: Adoption of FIN 48 (Accounting for Uncertainty in Income Taxes) resulted in a $2.2 million decrease to retained earnings and an increase in unrecognized tax benefits liability.

Guidance, Outlook, and Risks

• Outlook: Management expects the Infrared Optics segment to benefit from expanded material growth capacity and improved yields in the second half of fiscal 2008. The company anticipates continued expansion in addressable markets for CO2 laser optics.
• Liquidity: The company maintains a $60 million credit facility (expandable to $100 million) with $48.8 million available. Management believes cash flow from operations and existing reserves are sufficient to fund working capital, capital expenditures, and debt obligations for fiscal 2008.
• Risks and Contingencies:
  • Market Risk: Exposure to foreign currency exchange rates (primarily Japanese Yen, Euro, and Pound Sterling) and interest rate fluctuations.
  • Operational Risk: Yield and capacity challenges in the Infrared Optics segment.
  • Customer Concentration: Delays in large blanket orders from major medical customers impacted bookings in the Compound Semiconductor Group.
  • Tax Uncertainty: Ongoing IRS examination of fiscal years 2004-2007; gross unrecognized tax benefits totaled $7.5 million as of September 30, 2007.

Investor Verification Checklist

• Yield Improvements: Verify if the Infrared Optics segment successfully resolves material growth yield issues and expands capacity as projected for the second half of the fiscal year.
• Medical Sector Demand: Monitor the status of delayed medical imaging bookings in the Compound Semiconductor Group (eV PRODUCTS and Marlow) to assess future revenue stability.
• PRM Integration: Assess the ongoing contribution and margin profile of the newly acquired PRM business within the Military & Materials segment.
• Tax Liability: Review updates on the $7.5 million unrecognized tax benefits and the outcome of the IRS examination for fiscal years 2004-2007.
• Foreign Currency Exposure: Evaluate the impact of currency fluctuations on future earnings, given the significant international operations and the specific sensitivity noted for the Japanese Yen loan.